CYP19A1 and neoplasm: In a study reported by Braun et al. [16], tumor cells incubated with the aromatase inhibitor, formestane, became sensitized to killing by monocyte-mediated, antibody-dependent cellular cytotoxicity by an anti-MUC1 antibody.